Lee's Pharmaceutical (HK) Limited – Trademark Portfolio
Entity Type: 99
Lee's Pharmaceutical (HK) Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include LEE'S PHARM. The owner is based in Shatin,.
1/F, Building 20E, Phase 3,
Hong Kong Science Park,
Shatin, , HK
Showing of trademarks Trademarks
Trademark Classifications
Lee's Pharmaceutical (HK) Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Lee's Pharmaceutical (HK) Limited have?
Lee's Pharmaceutical (HK) Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Lee's Pharmaceutical (HK) Limited file in?
Lee's Pharmaceutical (HK) Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Lee's Pharmaceutical (HK) Limited's most well-known trademarks?
Lee's Pharmaceutical (HK) Limited's registered trademark portfolio includes well-known marks such as LEE'S PHARM. These are among 1 currently registered trademark in the portfolio.
What is Lee's Pharmaceutical (HK) Limited's trademark registration success rate?
Lee's Pharmaceutical (HK) Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.